All In Biotech

Drug Trial Radar · NCT01573403

Efficacy and Safety of DLBS2411 in Healthy Volunteers

Effect of DLBS2411 on Gastric pH Regulation in Healthy Volunteers : Comparison With Placebo

Last checked: Nov 19, 2026Latest source record: Feb 13, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

54

Actual

Start

Apr 2012

Primary completion

Dec 2012

Study completion Jan 2013

Sponsor

Lead sponsor
Dexa Medica GroupIndustry
Sponsor type
Industry
First posted
Apr 9, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a 3-arm, double-blind, randomized, controlled, parallel and dose ranging clinical study for 3 days of therapy to investigate the effect of DLBS2411 in gastric pH regulation as well as its safety in healthy volunteers. DLBS2411 has similar mechanism of action with proton-pump inhibitors (PPIs). However, it is hypothetically more potential than PPIs in suppressing gastric acid as our previous preclinical studies with DLBS2411 have proven its effects not only on the activity of H+/K+ ATPase, the enzyme that regulates proton pump in stomach, but also on its gene expression. It is hypothesized that DLBS2411 may benefit on gastric pH regulation in healthy volunteers.

Conditions

  • Gastric pH Regulation in Healthy Volunteers

Interventions

  • DLBS2411Drug

    1 caplet of DLBS2411 @250 mg and 1 placebo caplet, once daily

  • DLBS2411Drug

    2 caplets of DLBS2411 @250 mg, once daily

  • Placebo DLBS2411Drug

    2 placebo caplets of DLBS2411, once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of time over 24 hours during which gastric pH is > 4Time frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Division of Gastroenterology, Department of Internal Medicine, dr. Cipto Mangunkusumo Hospital

    Jakarta Center, Jakarta Special Capital Region, Indonesia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.